The British journal of dermatologyHumansIsotretinoinMaleAcne VulgarisDermatologic Agents
P05 The efficacy and safety of isotretinoin in transgender males receiving gender-affirming hormonal therapy with youth subgroup analysis: a systematic review.
Rachel Pugh, Tess McPherson
Published: 202510.1093/bjd/ljaf465.013
Abstract
BACKGROUND: Acne is a frequent effect of testosterone-based gender-affirming hormone therapy (GAHT), affecting up to 30% of transgender males within the first year. No formal guidelines address acne management or isotretinoin use in this population,…
Preview only. Read the full abstract at the source